Telo Genomics Corp. TDSGF
0.04 USD 0.00 (+11.11%)
At closeNov 5, 2026, 4:00 PM EST
0.036 Day range 0.036
0.018 52-week range 0.065
- YTD
- -20.00%
- 1 year
- +5.26%
- Market cap
- 4.02M
- EPS (ttm)
- -0.02
- YTD return
- -20.00%
- 1-year return
- +5.26%
- Volume
- 10.00K
- Avg volume
- 9.26K
- Open
- 0.036
- Previous close
- 0.036
- Day's range
- 0.036 – 0.036
- 52-week range
- 0.018 – 0.065
YTD -0.0140 (-28.00%)
News
TELO Genomics Expands Multi-Center Clinical Studies to Advance Comparative Validation of TELO-MRD Against Next-Generation Sequencing 
Telo Genomics Reports Additional Clinical Research Results Comparing Blood-Based TELO-MRD with Bone-Marrow Next-Generation Flow and Next-Generation Sequencing 
Telo Genomics Announces Clinical Research Results Evidencing Utility of Its Telomere Analysis Platform in Predicting Multiple Myeloma Relapse 
Telo Genomics Grants Stock Options 
Telo Genomics Provides Positive Interim Data from Ongoing Clinical Trial Advancing Genomic Instability-Based Relapse Risk Assessment 
Telo Genomics Files Patent to Expand IP Portfolio to Liquid Biopsy MRD Applications for Multiple Myeloma 
Telo Genomics Announces Termination of Investor Relations Agreement 
Telo Genomics Announces Study with University of Athens to Advance Next-Generation MRD Risk Stratification in Multiple Myeloma 
Telo Genomics Announces Appointment of John Farlinger as CEO and Chairman 
Telo Genomics Closes Second and Final Tranche of Convertible Debentures Financing
Your note
Sign in to keep a note on TDSGF — it syncs with the Stock Master app.